Akumin (TSX:AKU) Gross-Profit-to-Asset % : 5.65% (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Akumin Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Akumin's annualized Gross Profit for the quarter that ended in Sep. 2023 was C$122.2 Mil. Akumin's average Total Assets over the quarter that ended in Sep. 2023 was C$2,162.9 Mil. Therefore, Akumin's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 5.65%.

Akumin Gross-Profit-to-Asset % Historical Data

The historical data trend for Akumin's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Gross-Profit-to-Asset % Chart

Akumin Annual Data

Trend

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

17.56

6.26

6.05

5.01

7.91

Akumin Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															7.87	8.82	7.37	6.18	5.65

Competitive Comparison of Akumin's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Akumin's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akumin's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Akumin's Gross-Profit-to-Asset % falls into.

Akumin Gross-Profit-to-Asset % Calculation

Akumin's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	191.894	/	( (2456.097	+	2397.909)	/ 2 )
	=	191.894	/	2427.003
	=	7.91 %

Akumin's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	122.196	/	( (2173.247	+	2152.552)	/ 2 )
	=	122.196	/	2162.8995
	=	5.65 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Akumin Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Akumin's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (TSX:AKU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (TSX:AKU) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

AKUMQ:USA

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Marcus Quesenberry	Senior Officer
Amy Michelle Adams	Senior Officer

Akumin (TSX:AKU) Headlines

No Headlines